Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 0.00% is 100% below its 3-year average of 4.51%, near the high end of its 3-year range (-18187.74%–6113.38%).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
4.51%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
-100.00%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Amylyx Pharmaceuticals, Inc.
Market Cap
$3.12B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
4.51%
5Y Avg
0.00%
Market Cap
$3.06B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-93.42%
5Y Avg
-160.46%
Market Cap
$3.19B
Operating Margin
-8.00%
TTM Avg
-40.81%
3Y Avg
-286.27%
5Y Avg
-194.40%
Market Cap
$3.03B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$2.99B
Operating Margin
-3.25%
TTM Avg
-34.29%
3Y Avg
-2164.03%
5Y Avg
-1442.69%
Market Cap
$3.31B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$2.88B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$3.36B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Amylyx Pharmaceuticals, Inc. (AMLX) | $3.12B | 0.00% | 0.00% | 4.51% | 0.00% |
| Denali Therapeutics Inc. (DNLI)vs › | $3.06B | 0.00% | 0.00% | -93.42% | -160.46% |
| Tarsus Pharmaceuticals, Inc. (TARS)vs › | $3.19B | -8.00% | -40.81% | -286.27% | -194.40% |
| Enliven Therapeutics, Inc. (ELVN)vs › | $3.03B | 0.00% | 0.00% | 0.00% | 0.00% |
| Arcutis Biotherapeutics, Inc. (ARQT)vs › | $2.99B | -3.25% | -34.29% | -2164.03% | -1442.69% |
| CareDx, Inc (CDNA)vs › | $3.30B | -0.92% | 2.81% | -22.73% | -18.78% |
| Viking Therapeutics, Inc. (VKTX)vs › | $3.31B | 0.00% | 0.00% | 0.00% | 0.00% |
| Dyne Therapeutics, Inc. (DYN)vs › | $2.88B | 0.00% | 0.00% | 0.00% | 0.00% |
| Parabilis Medicines, Inc. (PBLS)vs › | $3.36B | 0.00% | 0.00% | 0.00% | 0.00% |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.38B | 7.59% | 16.94% | -4.86% | -19.92% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 6113.38% |
| 2024-09-30 | -18187.74% |
| 2024-06-30 | 5223.36% |
| 2024-03-31 | -137.78% |
| 2023-12-31 | 1.78% |
| 2023-09-30 | 18.23% |
| 2023-06-30 | 20.57% |
| 2023-03-31 | -2.87% |
| 2022-12-31 | -203.76% |
| 2022-09-30 | -15849.57% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
